LATEST ALERTS
This report provides a comprehensive overview of the current regulatory framework in place for CBD, cannabis and other cannabinoids, covering everything from cultivation and processing to finished products and import/export
The aim of this report is to analyse legal developments in the European Union related to the environment that are most likely to impact the cannabis/hemp vape sector, such as waste management and the phasing out of certain batteries
This report provides a detailed overview of the current regulatory framework in place in Portugal for hemp, cannabis and other cannabinoids, covering all policy areas
This report seeks to outline the labelling and packaging requirements that cannabis-containing medicinal products need to comply with when their placing on the European market is authorised
This report provides a detailed overview of the current regulatory framework in place for CBD and other cannabinoids, hemp and cannabis
CannIntelligence has analysed regulations and contacted authorities in the majority of European countries to determine the legality of IHDCs. This report presents our findings
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
The top European countries for importing and exporting cannabis for medical and scientific purposes covered in this report are slowly developing their frameworks with the primary goal of exporting and importing narcotics
This report provides a detailed overview of the current regulatory framework in place for hemp, cannabinoids and cannabis, covering everything from processing and cultivation to finished products, import/export and the countries medical and recreational cannabis regime
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in France, covering all areas from cultivation and processing to extracts and finished products
The aim of this report is to analyse EU legal developments related to the environment that are most likely to impact the cannabis and hemp-derived vape sector
This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Luxembourg. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country’s medical and recreational cannabis policies
This snapshot of the UK’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Austria. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country’s medical and recreational cannabis policies
This report seeks to outline the substance of the discussion at the EU level about the use of CBD and other hemp ingredients in cosmetic products, gleaned from documents CBD-Intel has obtained from EU authorities that show input provided by some member states on the matter, as requested by the European Commission
Hemp grown from EU-certified seeds or of less than 0.2% THC is exempt from the legal definition of cannabis in Estonia. This report offers a detailed overview of the legal regime for CBD, hemp and cannabis in Estonia
This report offers a detailed overview of Switzerland’s regulatory regime for cannabis, CBD and hemp, covering all policy areas and discussing future changes to the law
This report offers a detailed overview of the current legal regime for hemp, CBD and cannabis in the Czech Republic, covering all policy areas from cultivation and processing to extracts and finished products
This report offers a comprehensive overview of the regulatory framework for hemp, CBD and cannabis in the UK
The aim of this report is to provide a general overview of CBD advertising in nine countries in Europe
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
